[{"id":"d23a1df6-5a32-4fd2-9a4a-a76f94c1fd8d","acronym":"","url":"https://clinicaltrials.gov/study/NCT05173467","created_at":"2021-12-30T14:55:43.520Z","updated_at":"2024-07-02T16:36:19.028Z","phase":"","brief_title":"Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor","source_id_and_acronym":"NCT05173467","lead_sponsor":"Wei Xu","biomarkers":" MB","pipe":"","alterations":" ","tags":["MB"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 12/25/2021","start_date":" 12/25/2021","primary_txt":" Primary completion: 12/10/2022","primary_completion_date":" 12/10/2022","study_txt":" Completion: 12/10/2023","study_completion_date":" 12/10/2023","last_update_posted":"2021-12-30"},{"id":"077d9162-d559-485c-9149-55c8476adb7a","acronym":"THERANOVA","url":"https://clinicaltrials.gov/study/NCT03211676","created_at":"2021-01-18T15:50:25.999Z","updated_at":"2024-07-02T16:36:46.078Z","phase":"","brief_title":"Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer","source_id_and_acronym":"NCT03211676 - THERANOVA","lead_sponsor":"Poitiers University Hospital","biomarkers":" IL6 • TNFA • B2M • FGF23 • IL1B • LEP • MB","pipe":"","alterations":" ","tags":["IL6 • TNFA • B2M • FGF23 • IL1B • LEP • MB"],"overall_status":"Completed","enrollment":" Enrollment 49","initiation":"Initiation: 06/07/2017","start_date":" 06/07/2017","primary_txt":" Primary completion: 03/14/2018","primary_completion_date":" 03/14/2018","study_txt":" Completion: 06/14/2018","study_completion_date":" 06/14/2018","last_update_posted":"2020-04-13"}]